- Home
- ICG vs CKPT Comparison
ICG vs CKPT Comparison
Compare ICG & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICG
- CKPT
- Stock Information
- Founded
- ICG 2017
- CKPT 2014
- Country
- ICG China
- CKPT United States
- Employees
- ICG N/A
- CKPT N/A
- Industry
- ICG Semiconductors
- CKPT Biotechnology: Pharmaceutical Preparations
- Sector
- ICG Technology
- CKPT Health Care
- Exchange
- ICG Nasdaq
- CKPT Nasdaq
- Market Cap
- ICG 559.6M
- CKPT 214.4M
- IPO Year
- ICG 2023
- CKPT 2017
- Fundamental
- Price
- ICG $4.51
- CKPT $3.65
- Analyst Decision
- ICG Strong Buy
- CKPT Strong Buy
- Analyst Count
- ICG 1
- CKPT 2
- Target Price
- ICG $11.00
- CKPT $13.50
- AVG Volume (30 Days)
- ICG 582.9K
- CKPT 2.3M
- Earning Date
- ICG 02-26-2025
- CKPT 11-12-2024
- Dividend Yield
- ICG N/A
- CKPT N/A
- EPS Growth
- ICG N/A
- CKPT N/A
- EPS
- ICG 0.11
- CKPT N/A
- Revenue
- ICG $34,648,799.00
- CKPT $47,000.00
- Revenue This Year
- ICG N/A
- CKPT N/A
- Revenue Next Year
- ICG $74.94
- CKPT $216,182.69
- P/E Ratio
- ICG $40.53
- CKPT N/A
- Revenue Growth
- ICG 202.16
- CKPT N/A
- 52 Week Low
- ICG $2.80
- CKPT $1.38
- 52 Week High
- ICG $14.22
- CKPT $4.50
- Technical
- Relative Strength Index (RSI)
- ICG 47.16
- CKPT 51.30
- Support Level
- ICG $2.80
- CKPT $3.12
- Resistance Level
- ICG $7.95
- CKPT $4.44
- Average True Range (ATR)
- ICG 2.11
- CKPT 0.43
- MACD
- ICG -0.24
- CKPT -0.04
- Stochastic Oscillator
- ICG 18.51
- CKPT 45.89
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments.
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.